ARTICLE | Clinical News
Genentech regulatory update
December 20, 1993 8:00 AM UTC
Genentech Inc. (GNE) The European Committee for Proprietary Medicinal Products voted unanimously in favor of marketing approval for GNE's Pulmozyme DNase treatment for cystic fibrosis. F. Hoffmann-La...